Statistics for Perspective Therapeutics, Common Stock (id:170 CATX)
Valuation metrics
Market cap
270.35M
Enterprise value
6.77M
Trailing P/E (ttm)
-1.68
Forward P/E
-3.70
PEG ratio
-3.70
Price/Sales (ttm)
173.64
Price/Book (mrq)
3.00
Enterprise Value/Revenue
4.35
Enterprise Value/EBITDA
3.00
Overview
Shares outstanding
67.59M
Float
43.46M
Shares short
8.28M
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
4.13M
Average volume (90 days)
Price summary
52-Week low
2.70
52-Week high
19.10
52-Week change
-50.88%
Beta
1.47
50-Day moving average
10.60
200-Day moving average
12.63
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
June 17, 2024
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
0.00%
Operating margin
-5,049.86%
Operational effectiveness
Return on assets
-14.35%
Return on equity
-27.02%
Income statement
Revenue (ttm)
5.00
Revenue per share (ttm)
5.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-55,762,000.00
Net income to common (ttm)
-57,712,000.00
Diluted EPS (ttm)
-1.33
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
267.85M
Total cash per share (mrq)
3.96
Total debt (mrq)
4.27M
Total Debt/Equity (mrq)
1.30
Current ratio (mrq)
960.00%
Book value per share (mrq)
4.86
Cash flow
Cash flow statement
-696,000.00
Levered free cash flow (LFCF)
-49,486,876.00